March 11 Quick Takes: PDL, Kala, InnoCare, LifeSci, BioSight, BillionToOne, SEC

PDL to dissolve by year-end
PDL BioPharma Inc. (NASDAQ:PDLI) said it will cease operations and seek to sell the company or monetize its assets. PDL acquires commercial-stage pharmaceutical assets and late clinical stage products. On Monday, the company said VP, Chief Accounting Officer and acting CFO Edward Imbrogno will become the permanent CFO.

Kala raises $126M follow-on
Kala Pharmaceuticals Inc. (NASDAQ:KALA) raised $126.2 million late Tuesday through the sale of 16 million shares at $7.89, the same price as its close that day, when it proposed the offering after hours. The company is developing eye disease therapies using its mucus penetrating drug delivery technology. ...